PRDX1 and pachyonychia congenita: Other authors found that serum peroxiredoxin-1 (Prx-1) concentrations were higher in patients with PC patients than in healthy controls and that their diagnostic value was higher when used in combination with serum CA19-9 than when each biomarker was considered individually [87].